How does KGM’s positive influence on lipid profiles contribute to reducing the body's systemic inflammatory burden?
High cholesterol, particularly LDL-C levels, are known contributors to cardiovascular inflammation.
The anti-inflammatory effects of Konjac Glucomannan are deeply interconnected with its established metabolic benefits, forming a synergistic protective effect on the body's overall inflammatory status. One major pathway involves lipid management: KGM is highly effective at lowering total cholesterol and specifically LDL-C levels. Elevated levels of these lipids are scientifically recognized risk factors that actively contribute to the development and progression of cardiovascular inflammation. By directly reducing the circulating levels of these pro-atherogenic lipids, KGM lessens the underlying stimuli that drive chronic cardiovascular inflammatory states, thereby reducing the overall systemic inflammatory burden sustained by the individual over time.
